MRI-based imaging to guide treatment in nasopharyngeal cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study uses special MRI images (and computer “radiomics” scores) to better understand nasopharyngeal cancer. The goal is to help doctors choose the most appropriate treatment for people with newly diagnosed cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed nasopharyngeal carcinoma that is confirmed by biopsy (non-keratinizing or keratinizing type)
- Your general health is good, with an ECOG score of 0–1 (able to carry out most daily activities)
- Your blood counts are adequate: white blood cells, hemoglobin, and platelets are above set minimums
- Your liver and kidneys are working well (liver tests within 2.5× normal; kidney function with creatinine clearance ≥60)
- You can have MRI scans safely and are able to follow the study plan
- You have not had chemotherapy or radiotherapy before (except certain limited exceptions for skin cancers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from people with newly diagnosed nasopharyngeal cancer to find biological markers that might help predict how the disease behaves. By joining, you help researchers learn more about the disease and potentially improve future treatments.
This study uses advanced testing (multi-omics) to predict if combining chemoradiation with immunotherapy works better for nasopharyngeal cancer that has returned or spread. It aims to find the right treatment for each person.
This trial tests a new computer-based tool (deep learning) to help diagnose a condition called sbORN (suspected benign or recurrent nasopharyngeal carcinoma) after radiation therapy. It aims to see if the tool can accurately tell if a suspicious spot is a recurrence or something harmless.
This trial tests a new type of radiation therapy that adjusts in real-time to treat nasopharyngeal cancer. It is for people who have not received prior radiation and have no distant spread of cancer.
This trial uses a special combined PET and MRI scan to get a detailed picture of advanced nasopharyngeal cancer before starting treatment. The goal is to see how well this imaging method helps doctors plan the best care.
This trial tests whether combining a special scope (NBI) with MRI scans can help doctors better target radiation therapy for a specific type of nose/throat cancer that affects only one side. It aims to make treatment more precise and reduce side effects.
Hear when a new Nasopharyngeal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.